Roivant Sciences Ltd. (ROIV) earnings: date, estimates, results and stock reactions
Next earnings: Q3 FY2026 on 2027-02-05 (expected, time not announced). EPS estimate -0.36, revenue estimate 50.6M.
Over the last 12 reports the stock moved 5.9% on average (either way), rising 8 times and falling 4. EPS beat estimates 8 of 12 times; revenue 4 of 12. Close before the report date to the first close after it (two trading sessions, covering before-the-open and after-the-close reports).
| Quarter | Reported | EPS | EPS estimate | EPS surprise | Revenue | Revenue estimate | Stock move |
|---|---|---|---|---|---|---|---|
| Q2 FY2026 | 2026-11-09 | -0.27 | -0.37 | +26.4% | 35.1M | 4.3M | +5.9% |
| Q1 FY2026 | 2026-08-06 | -0.33 | -0.30 | -10.1% | 1.4M | 2.1M | +5.0% |
| Q4 FY2025 | 2026-05-20 | -0.28 | -0.29 | +3.5% | 2.5M | 3.4M | +9.5% |
| Q3 FY2025 | 2026-02-06 | -0.24 | -0.30 | +19.9% | 2.0M | 5.1M | +30.9% |
| Q2 FY2025 | 2025-11-10 | -0.20 | -0.32 | +36.9% | 1.6M | 5.6M | +1.4% |
| Q1 FY2025 | 2025-08-11 | -0.25 | -0.25 | -0.8% | 2.2M | 7.3M | +0.7% |
| Q4 FY2024 | 2025-05-29 | -0.29 | -0.26 | -10.1% | 7.6M | 54.1M | +3.5% |
| Q3 FY2024 | 2025-02-10 | -0.23 | -0.25 | +9.0% | 9.0M | 5.0M | -3.7% |